I am a tumor biologist and immunologist studying the phenotypic plasticity of cells in the tumor microenvironment.
Bonn, Germany
Joined April 2018
- Tweets108
- Following552
- Followers441
- Likes351
Tobias Bald retweeted
In three Phase III trials (mUC: IMvigor211, mRCC: IMmotion151, NSCLC: OAK) immunotherapy prolonged OS when baseline serum albumin was >35g/L -> Prediction of less immune fitness via simple albumin measurement?onlinelibrary.wiley.com/doi/… @OncoAlert @ClinTransImmuno @Doc_Bald @IEO_Bonn
Tobias Bald retweeted
Excellent presentation by Gonzalo at the Single Domain Antibodies Meeting 2023 in Paris on his generic #CRISPR #CAR T cell platform! Important tool to improve #cellular #cancer #immunotherapies @UniBonn @ImmunoSens @MSSOabcd @IEO_GloddeLab
Tobias Bald retweeted
Happy to share our work: Integrating On-Treatment Modified Glasgow Prognostic Score and Imaging to Predict Response and Outcomes in Metastatic Renal Cell Carcinoma @JAMAOnc. See our tweetorial and the terrific editorial by @ggebraelmd @GliceidaGalarza @neerajaiims @urotoday 1/7
Integrating on-treatment mGPS (CRP + albumin) for a more holistic and patient-centered therapy monitoring in addition to radiological staging may improve outcome prediction for patients with mRCC. @saal_jonas @niklas_kluemper @IEO_HolzelLab @UniklinikBonn ja.ma/46lcw3q
Tobias Bald retweeted
After 5 days of #science and networking, the ImmunoSensation2 SummerSchool "#Immunology at scales" comes to an end. We hope everyone had a great time at Schwanenwerda #Abendsonne 😉
Also want to be a #PhD #Student @ImmunoSens? 👉immunosensation.de/opportuni…
Well done Fenna!!! You are a fantastic PhD student keep up with the good science! Thanks @UniBonn, @UniMelb and @BonnMelbPhD for this great Retreat!
Final day of our retreat: big thanks to Andreas @DrAndy92 & Abdalla @abdalla42353282 for sharing their experiences with the joint PhD @UniMelb @UniBonn & congratulations to Fenna Feenstra @IEO_baldlab & Helena @HelenaHorvatic for receiving our awards for the best talk/ poster 🏆
Longitudinal CRP kinetics (CRP Flare :fire:) predicts immunotherapy response within the first month in NSCLC! Great tool for therapy monitoring and as an integral biomarker for biomarker-directed study design @niklas_kluemper @Doc_Bald @IEO_BaldLab @IEO_Bonn @ImmunoSens @UniBonn
New #JITC short report: C reactive protein flare predicts response to checkpoint inhibitor treatment in non-small cell lung cancer jitc.bmj.com/content/10/3/e0… @niklas_kluemper @Doc_Bald
Tobias Bald retweeted
Longitudinal CRP kinetics (CRP Flare 🔥) predicts immunotherapy response within the first month in NSCLC! Great tool for therapy monitoring and as an integral biomarker for biomarker-directed study design @niklas_kluemper @Doc_Bald @IEO_BaldLab @IEO_Bonn @ImmunoSens @UniBonn
CRP flare 🔥! Longitudinal CRP kinetics predicts response to immunotherapy in NSCLC as early as 4 weeks after therapy start. Simple on-treatment biomarker to optimize monitoring. Chance for early therapy adjustments. Thanks to all collaborators! @docbald @IEO_HolzelLab @UniBonn
Tobias Bald retweeted
We are excited to welcome Prof Tobias Bald @IEO_baldlab @UniBonn & Prof @MarcoHerold_J @WEHI_research @UniMelbMDHS as new PIs to our program! DFG funding @dfg_public for their project investigating CD155-CD226 interactions for T cell functionality in cancer has been approved 🥳
Tobias Bald retweeted
CRP as biomarker to predict responses to immune checkpoint inhibitors in patients with metastatic renal cancer. Great potential for the clinic as simple and cost-effective. Congrats to @niklas_kluemper @UniklinikBonn and collaborators.
onlinelibrary.wiley.com/doi/…
Tobias Bald retweeted
New paper published by Klümper et al. about CRP as a biomarker in metastatic renal cancer. Congratulations to all collaborators🎉@niklas_kluemper
CRP as biomarker to predict responses to immune checkpoint inhibitors in patients with metastatic renal cancer. Great potential for the clinic as simple and cost-effective. Congrats to @niklas_kluemper @UniklinikBonn and collaborators.
onlinelibrary.wiley.com/doi/…
Tobias Bald retweeted
🥳Attention science enthusiasts🥳We are excited to announce the launch of our new IEO website. Check it out to find out more about our research and spread the word 🎉ieo.uni-bonn.de @ImmunoSens @HCM_Bonn @UniklinikBonn @UniBonn
Tobias Bald retweeted
Dieser Text von Paul Offit, dem führenden Kinder Impfspezialisten in den USA, erklärt überzeugend, weshalb auch Kinder im Alter 5-12 J geimpft werden sollten. Sehr lesenswert. Den Impfstoff werden wir bald auch in Deutschland haben, ich schätze vor Weihnachten
The compelling case for vaccination in kids
science.org/doi/10.1126/scie…
@ScienceMagazine
"Vaccinating all children against SARS-CoV-2 could be among the most impactful public health efforts the US has seen in decades."
Tobias Bald retweeted
We are happy to share the most recent publication from our Institute by PhD student @InesKalt describing Hip Kinases as a target of the FDA approved cancer drug Abemaciclib. Read the full article in @NatureComms here: nature.com/articles/s41467-0…
Tobias Bald retweeted
👏Congratulations to @Doc_Bald for recieving the Lisec-Artz Prize, together with Sebastian Kobold! Well deserved! @UniBonn @UniklinikBonn @IEO_baldlab
Tobias Bald retweeted
LAMP-Seq with 1-enzyme protocol out today go.nature.com/3y85GfE, grateful to colleagues @ Bonn&Boston! @k_u_ludwig @RSchmithausen @_David_Li @ronhollstein @biomiko @NIshorst @LMHighfield @evabeins @InesKalt @MaxSticks7 @ern_esth @jacobborrajo @thestrecker @HolzelMichael @zhangf
Tobias Bald retweeted
Absolutely thrilled to see this work finally published! About 15 months ago I started on a journey which I could not have imagined before… Interested in the story behind the scenes? My first-ever thread. 1/n
LAMP-Seq enables sensitive, multiplexed COVID-19 diagnostics using molecular barcoding go.nature.com/3y85GfE
Tobias Bald retweeted
🚨 JOB ALERTS 🚨
We are hiring!
Fully funded PhD and Postdoc positions available!
Come work with us! @LabSchultze
Great team, infrastructure and scientific environment!
🗓️ Apply until April 30!
Tobias Bald retweeted
Check out new @GrasLab study on SARS-CoV-2 CD8+ T cell response. Well done to co-first authors @Emma_J_Grant and Dimitra from @GrasLab and Katie Lineburg & Srividhya Swaminathan from @QIMRBerghofer
Our study on SARS-CoV-2 CD8+ T cell response is now online @ImmunityCP.
Thanks to the fantastic collaboration between @MonashBDI @LIMSLTU @latrobe @QIMRBerghofer @UQMedicine @ANSTO @uwanews with Corey Smith and @K_RenfreeShort and everyone involved 👏
cell.com/immunity/fulltext/S…
